Efficacy and safety of Jinhu Gushen Recipe in the treatment of diabetic kidney disease

The Affiliated Hospital of Medicine College Qingdao University0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Patients who meet the diagnostic criteria for type 2 diabetes in the 2017 China Type 2 Diabetes Prevention and Control Guidelines;
•2. Gender is not limited, aged between 18-80 years;
•3. Patients with DKD meet the diagnostic criteria for DKD, in stage III or IV in Mogensen.

•1. eGFR<30 mL/min/1.73m2 (MDRD formula).
•2. Patients in need of dialysis or kidney transplantation.
•3. Special medication: Any kind of traditional Chinese medicine for kidney disease have been used in the past 3 months; patients who have used nephrotoxic drugs and antioxidants within the past 2 weeks, or systemically used glucocorticoid therapy.
•4. Acute coronary syndrome (ACS), transient ischemic attack (TIA), stroke, decompensated heart failure, persistent ventricular tachycardia occurred within 3 months before screening.
•5. Patients with a history of nephrotic syndrome or glomerulonephritis in the past 3 months, or other causes of elevated urine albumin.
•6. Patients with severe liver disease (ALT and/or AST more than three times the normal value, and/or total bilirubin> 34.2µmol/L).
•7. Pregnant or lactating women, allergic physique and patients allergic to the drug used in this test.

发起方

The Affiliated Hospital of Medicine College Qingdao University